Humanigen Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	2017 - 2013
Net Income	-53.63	-70.73	-236.65	-89.54	-10.29	-12	Upgrade
Depreciation & Amortization	0	0	0	0	0	0.02	Upgrade
Share-Based Compensation	5.49	5.81	5.37	2.49	2.25	4.98	Upgrade
Other Operating Activities	-16.17	-11.78	47.24	17.19	4.05	0.8	Upgrade
Operating Cash Flow	-64.32	-76.7	-184.05	-69.85	-4	-6.21	Upgrade
Other Investing Activities	-	-	-	-0.02	-	-	Upgrade
Investing Cash Flow	0	0	0	-0.02	0	0	Upgrade
Share Issuance / Repurchase	23.47	41.84	161.88	140.33	0.51	2.78	Upgrade
Debt Issued / Paid	-25.01	-25.01	24.44	-2.87	2.82	3.48	Upgrade
Financing Cash Flow	-1.54	16.84	186.32	137.47	3.33	6.26	Upgrade
Net Cash Flow	-65.85	-59.86	2.28	67.59	-0.67	0.05	Upgrade
Free Cash Flow	-64.32	-76.7	-184.05	-69.85	-4	-6.21	Upgrade
Free Cash Flow Margin	-3785.46%	-3050.84%	-5119.47%	-22388.46%	-	-	Upgrade
Free Cash Flow Per Share	-0.54	-0.86	-3.14	-1.89	-0.18	-0.33	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).